• Latest Posts

Mass Layoffs as Dutch Biotech Cancels Phase III Cell Therapy Trial

UK Biotech Launched to Target ‘Dark Antigens’ with Cancer Vaccines

EU Regulations Are Holding Back Gene and Cell Therapy Clinical Trials

Mogrify Raises €15M Series A to Chase the ‘Holy Grail’ of Cell Therapy

Startup Scout 11 Oct 2019

This Biotech Is Developing a Stem Cell Therapy for Deafness

Startup Scout 27 Sep 2019

This Biotech Can Screen CAR T-Cells Using Only Light and Microfluidics


Grünenthal to Pay up to €900M for Chronic Low Back Pain Cell Therapy

Italian Biotech Raises €13M to Test Stem Cell Therapy for Cancer

4BIO Capital Raises €45M Fund to Invest in Advanced Therapies

UK Biotech’s Personalized Immunotherapy gets €110M Series B Boost

Off-the-Shelf Kidney Cancer Immunotherapy More Than Doubles Recovery in Phase II

Swiss Scientists Upgrade CRISPR to Edit Many Genes at Once